tirzepatide type 1 diabetes trial Groundbreaking Testing for Tirzepatide in Adults With Type

doi: 10.1016/S0140-6736(23)02750-2 Wing RR, Phelan S

The medication's effects on appetite and satiety are mediated through central nervous system pathways, particularly in areas of the brain that regulate hunger and food intake

The exact price depends on medication type and dosage

The results were notable: participants receiving the highest dose (12 mg weekly) achieved a mean body weight reduction of approximately 24% from baseline

In addition, activated platelets release soluble CD154, which can interact with vascular cells (including endothelial cells) and induce the upregulation of E-selectin and P-selectin and the release of IL-6 and tissue factor 35,36

More capillaries mean better nutrient delivery and waste removal, supporting all aspects of tissue repair